Cibc Private Wealth Group, LLC Tg Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,439 shares of TGTX stock, worth $43,313. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,439
Previous 1,689
14.8%
Holding current value
$43,313
Previous $30,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TGTX
# of Institutions
338Shares Held
87.7MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$463 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$343 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$274 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$108 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$96.5 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.37B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...